We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Effects of donor age on superior cervical ganglion transplants: evaluation by Falck-Hillarp histochemistry and immunocytochemistry | SpringerLink

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effects of donor age on superior cervical ganglion transplants: evaluation by Falck-Hillarp histochemistry and immunocytochemistry

  • 59 Accesses

  • 12 Citations

Summary

The purpose of the present study was to investigate the viability, growth characteristics and neuropeptide expression of intraocular superior cervical ganglia (SCG) grafts from neonatal (1–3 d), mature (4–5 months) and aged (20–24 months) rats. In vivo measurements, Falck-Hillarp histochemistry using iris whole mounts to assess catecholamine fiber outgrowth and immuno-cytochemical localization of tyrosine hydroxylase (TH-), neuropeptide Y (NPY-), leu-enkephalin (ENK-) and calcitonin gene-related peptide (CGRP-) like immuno-reactivity (LI) were used. Measurements indicated a marked decrease in volume during the first week after grafting and a more gradual decrease thereafter. This was most evident in newborn SCG. With prolonged survival time, the newborn ganglia demonstrated more varicose nerve terminals and increased catecholamine fiber outgrowth and arborization. Extensive and complex outgrowth of catecholamine fibers with varicose nerve terminals occurred more rapidly with mature and aged ganglia. In situ, all ganglion cell bodies and fibers demonstrated TH-LI. Localization of TH-LI after grafting indicated an increase in fiber density and a decrease in cell body density of 65%, 40% and 40% in newborn, mature and aged ganglia respectively. NPY-LI in cell bodies had a perinuclear fluorescence pattern consistent with localization in the Golgi apparatus. Grafting of newborn, mature and aged SCG resulted in a 20%, 20% and 35% decrease respectively of cell bodies containing NPY-LI. A concommitant increase in fiber diameter, fluorescence intensity and extent of arborization was observed. The characteristic distribution of ENK-LI in cell bodies and axons in mature and aged ganglia was not affected by grafting. However, there was a greater than 50% reduction in the number of cell bodies expressing ENK-LI. CGRP-LI, localized in fibers and axon terminals in SCG in situ, was not identified after grafting. In summary, we have demonstrated that SCG from all age groups form extensive fiber networks and continue neuropeptide expression after intraocular grafting. This was seen best in mature and aged donors and may suggest a role for SCG transplants in the replacement of monoaminergic neurons in the CNS.

References

  1. Ariano M, Kenny S (1985) Peptide coincidence in rat superior cervical ganglion. Brain Res 340:181–185

  2. Backlund E-O, Sedvall G, Seiger Å, Olson L (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism. J Neurosurg 62:169–173

  3. Björklund A, Lindvall O, Isacsson B, Brundin P, Wictorin K, Strecker R, Clarke D, Dunnett S (1987) Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum. TINS 10:509–516

  4. Björklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555–560

  5. Björklund H, Olson L, Seiger Å, Hoffer B (1980) Chronic lead and brain development: intraocular brain grafts as a method to reveal regional and temporal effects in the central nervous system. Environ Res 22:224–236

  6. Coons AH (1958) Fluorescent antibody methods. In: Danielli JF (eds) General cytochemical methods. Academic Press, New York, pp 399–422

  7. Ebendal T, Olson L, Seiger Å, Hedlund K-O (1980) Nerve growth factors in the rat iris. Nature 236:25–28

  8. Falck B, Hillarp NÅ, Thieme G, Torp A (1962) Fluorescence of catecholamines and related compounds condensed with formaldehyde. J Histochem Cytochem 10:348–354

  9. Fukuda J, Yamaguchi K, Akimoto S Tada Y (1985) NGF dependent and independent growth of neurites from sympathetic ganglion cells of the aged human in a serum-free culture. Neurosci Res 2:460–471

  10. Goetz CG, Olanow CW, Koller WC, Penn RD, Cahill D, Morantz R, Stebbins G, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt T, Cox C (1989) Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320:337–341

  11. Goodman EC, Iverson L (1986) Calcitonin gene-related peptide: novel neuropeptide. Life Sci 38:2169–2178

  12. Gray T, Morley J (1986) Neuropeptide Y: anatomic distribution and possible function in mammalian nervous system. Life Sci 38:389–401

  13. Hamburger V (1975) Cell death in the development of the lateral motor column of the chick embryo. Comp Neurol 160:535–546

  14. Hökfelt T, Fuxe K, Goldstein M, Joh T (1973) Immunohistochemical localization of three catecholamine synthesizing enzymes: aspects on methodology. Histochemie 33:231–254

  15. Itakura T, Kamei I, Nakai K, Naka Y, Nakakitu K, Imai H, Okuno T, Kaumi N (1986) Transplantation of the superior cervical ganglion into the brain of the monkey with experimental Parkinson's disease. Appl. Neurophysiol 49:290

  16. Järvi R, Helen P, Markku P-H, Hervonen A (1986) Neuropeptide Y (NPY)-like immunoreactivity in rat sympathetic neurons and small granule-containing cells. Neurosci Lett 67:223–227

  17. Jiao S, Zhang W, Cao J, Zhang Z, Wang H, Ding M, Zhang Z, Sun J, Sun Y, Shi M (1988) Study of adrenal medullary tissue transplantation to striatum in parkinsonism. Progr Brain Res 78:575–580

  18. Johnson B, Nogueira-Araujo G de C (1981) A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Meth 43:349–350

  19. Kamo H, Kim S, McGeer P, Shin D (1986) Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons. Brain Res 397:372–376

  20. Landmesser L, Pilar G (1974) Synaptic transmission and cell death during normal ganglionic development. J Physiol (Lond) 241:737–750

  21. Landmesser L, Pilar G (1976) Fate of ganglionic synapses and ganglion cell axons during normal and induced cell death. J Cell Biol 63:357–374

  22. Lee Y, Tokami K, Kawai Y, Girgis S, Hillyard C, MacIntyre F, Emson P, Tohyama M (1985) Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience 15:1227–1237

  23. Levi-Montalcini R (1982) Developmental neurobiology and the natural history of nerve growth factor. Ann Rev Neurosci 5:341–362

  24. Lindvall O, Backlund E-O, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger Å, Olson L (1987) Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457–468

  25. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawley G, Rothwell JC, Marsden CD, Björklund A (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574–577

  26. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Åstedt B, Widner H, Lindholm T, Björklund A, Leenders KL, Rothwell JC, Frackowiak R, Marsden CD, Johnels B, Steg G, Freedman R, Hoffer BJ, Seiger Å, Bygdeman M, Strömberg I, Olson L (1989) Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methology and a 6-month follow-up. Arch Neurol 46:615–631

  27. Lundberg J, Terenius L, Hökfelt T, Martling C, Tatemoto K, Mutt V, Polak J, Bloom S, Goldstein M (1982) Neuropeptide Y (NPY) -like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 116:477–480

  28. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J, Torres C, Beurril J (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. New England J Med 316:831–834

  29. Malmfors T (1965) Studies on adrenergic nerves. The use of rat and mouse iris for direct observations in their physiology and pharmacology at cellular and subcellular levels. Acta Physiol Scand 64, Suppl 248:1–93

  30. Olson L, Backlund E-O, Gerhardt G, Hoffer B, Lindvall O, Rose G, Seiger Å, Strömberg I (1986) Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies. In: Yahr MD, Bergman KJ (eds) Advances in neurology, Vol 45. Raven Press, New York, pp 85–94

  31. Olson L, Backlund E-O, Sedvall G, Herrera-Marschitz M, Ungerstedt U, Strömberg I, Hoffer B, Seiger Å (1984) Intrastriatal chromaffin grafts in experimental and clinical parkinsonism: first impressions. In: Usdin E, Carlsson A, Dahlström A, Engel J (eds) Catecholamines, Part C. Neuropharmacology and central nervous system: therapeutic aspects. Neurology and neurobiology, Vol 8C. Alan R. Liss, New York, pp 195–201

  32. Olson L, Malmfors T (1970) Growth characteristics of adrenergic nerves in the adult rat. Acta Physiol Scand Suppl 348:9–111

  33. Olson L, Seiger Å, Strömberg I (1983) Intraocular transplantation in rodents: a detailed account of the procedure and examples of its use in neurobiology with special reference to brain tissue grafting. In: Fedoroff S, Hertz L (eds) Advances in cellular neurobiology, Vol 4. Academic Press, New York, pp 407–442

  34. Penn RD, Goetz CG, Tanner CM, Klawans HL, Shannon KM, Comella CL, Witt TR (1988) The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patients. Neurosurg 22:999–1004

  35. Perlow M, Freed W, Hoffer B, Seiger Å, Olson L, Wyatt R (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643–646

  36. Platt JL, Michael AF (1983) Retardation of fading and enhancement of intensity of immunofluorescence of p-phenylenediamine. J Histochem Cytochem 31:840–842

  37. Schultzberg M, Hökfelt T, Terenius L, Elfvin L-G, Lundberg J, Brandt J, Elde R, Goldstein M (1979) Enkephalin immunoreactive nerve fibers and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neurosci 4:249–270

  38. Stenevi U, Björklund A, Svengaaard N-A (1976) Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res 114:1–20

  39. Terenghi G, Polak JM, Ghatei M; Mulderry P, Butler J, Unger W, Blom S (1985) Distribution and origin of calcitonin gene-related peptide (CGRP) immunoreactivity in the sensory innervation of the mammalian eye. J Comp Neurol 233:506–516

  40. Uchida Y, Tomonaga M (1985) Effects of nerve growth factor and heart cell conditioned medium on neurite regeneration of aged sympathetic neurons in culture. Brain Res 348:100–106

Download references

Author information

Correspondence to L. Olson.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stieg, P., Strömberg, I. & Olson, L. Effects of donor age on superior cervical ganglion transplants: evaluation by Falck-Hillarp histochemistry and immunocytochemistry. Exp Brain Res 85, 55–65 (1991). https://doi.org/10.1007/BF00229986

Download citation

Key words

  • Superior cervical ganglion
  • Intraocular
  • Transplants
  • Tyrosine hydroxylase
  • Neuropeptide Y
  • Enkephalin
  • Calcitonin gene-related peptide
  • Neuro-peptide-‘like immunoreactivity’
  • Rat